How COVID-10 is affecting cardiology: ACE2 fears and cath lab curbs

An analysis of comorbidities in three series of COVID-19 cases from Wuhan in China supports an association between increased expression of angiotensin-converting enzyme 2 (ACE2) and more severe and fatal disease. The correspondence, published in Lancet Respiratory Medicine, said the most frequent comorbidities reported in patients with COVID-19 were often treated with ACE inhibitors. The ...

Already a member?

Login to keep reading.

© 2021 the limbic